The Review of European and Comparative Law, published by the John Paul II Catholic University of Lublin, serves as a prominent platform for interdisciplinary scholarship within the realm of legal studies. Since its establishment in 2016 as an Open Access journal, it has made significant strides in disseminating pivotal research that explores the intricate relationship between European and comparative legal systems. Aimed at fostering a deeper understanding of legal principles across differing jurisdictions, this journal provides an invaluable resource for researchers, legal practitioners, and students alike. By offering free and unrestricted access to its content, the journal not only enhances the visibility of groundbreaking legal scholarship but also encourages global discourse on contemporary legal issues. With a commitment to high-quality research and a growing repository of scholarly articles, the Review of European and Comparative Law is an essential read for those engaged in the dynamic field of law.

The European Journal of Health Law, published by Brill, stands as a pivotal resource for scholars and practitioners at the intersection of health policy and law since its inception in 1994. This esteemed journal, with an ISSN of 0929-0273 and an E-ISSN of 1571-8093, delves into pressing issues affecting health law across Europe and beyond, providing a platform for rigorous scholarly discourse. It is categorized in the Q4 quartile for Health Policy and Q3 for Law, highlighting its crucial role in advancing knowledge in these fields. While the journal is not an open-access publication, its content remains vital for researchers, students, and professionals seeking to navigate the complexities of health law amidst evolving legal frameworks. With an increasing focus on interdisciplinary studies, the journal aims to foster a deeper understanding of legal principles and their application to health care governance, policy-making, and ethical considerations, making it an indispensable reference for those committed to enhancing health law practice and scholarship.

MEDICINE SCIENCE AND THE LAW is a prestigious journal published by SAGE PUBLICATIONS INC, focused on the intersection of law, health policy, and ethical issues as they pertain to medicine. With a long-standing history dating back to 1960, this journal has become a crucial platform for scholars and professionals alike to share and disseminate research that shapes the evolving legal landscape surrounding health care practices. It holds notable positions in the academic community, ranking in the Q3 category for Health Policy and Issues, Ethics and Legal Aspects, and achieving a distinguished Q1 ranking in Law as of 2023. With rigorous peer-review standards and a commitment to publishing high-quality research, MEDICINE SCIENCE AND THE LAW is invaluable for those exploring the critical legal challenges and ethical dilemmas faced within the healthcare sector. Research contributions are vital for informing policy and practice, ensuring that the journal remains a relevant and essential resource for researchers, practitioners, and students dedicated to the intersection of law and medicine.

JAMA - Journal of the American Medical Association, published by the American Medical Association, stands as a leading voice in the field of medicine, with an impressive impact factor that reflects its status as a pivotal resource for health professionals. Established in 1883, JAMA has consistently evolved to meet the changing landscape of medical research and practice, converging its insights into the realm of general medicine through to 2024. As a Q1 journal in the Medicine (miscellaneous) category, JAMA ranks notably at #6 out of 636 in Scopus, placing it within the 99th percentile of its field. Although it does not currently offer open access options, JAMA remains a critical platform for disseminating groundbreaking research and clinical studies, facilitating engagement among researchers, healthcare professionals, and students alike. Its commitment to advancing health knowledge makes it an indispensable asset for anyone dedicated to the pursuit of excellence in medical science.

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.

Acta Bioethica is a pivotal open access journal published by the Universidad de Chile's Centro Interdisciplinario de Estudios Bioética, dedicated to the multidisciplinary exploration of bioethical issues in health policy and social sciences. Since its inception in 2000, the journal has fostered dialogue among researchers, professionals, and students, addressing the complexities of ethical practices in diverse health contexts. With an impressive commitment to accessibility, Acta Bioethica has become a vital resource for those engaged in understanding the ethics of healthcare in Latin America and beyond. Although currently ranked in the lower quartiles of Scopus in both health policy and social sciences, the journal is steadily gaining recognition for its unique contributions to bioethics. The journal accepts contributions in both English and Spanish, ensuring a wider reach and impact in the academic community. Located in Santiago, Chile, and active from 2007 to 2024, Acta Bioethica continues to be an essential platform for advancing research and discussions in the ever-evolving field of bioethics.

The HASTINGS CENTER REPORT, published by WILEY, is a leading journal in the fields of bioethics, health policy, and the philosophical underpinnings of healthcare. Established in 1971, this influential publication provides a critical platform for the discussion of ethical issues in health, medicine, and biotechnology, highlighting the intersection between ethical theory and practical health challenges. The journal achieves remarkable academic stature, achieving Q1 rankings in both Issues, Ethics and Legal Aspects and Philosophy, alongside Q2 standings in Health Policy and Health (social science) categories, reflecting its broad interdisciplinary impact. With its wide readership and rigorous peer-review process, the HASTINGS CENTER REPORT serves as an essential resource for researchers, practitioners, and students dedicated to advancing ethical perspectives in health-related discourse. While the journal operates under traditional access options, its contributions resonate deeply within the academic community, fostering informed dialogue on pressing ethical dilemmas and policy considerations in a rapidly evolving healthcare landscape.

BMC Medical Ethics is a leading open-access journal dedicated to the critical exploration and dissemination of knowledge surrounding ethical issues in healthcare and medicine. Published by BMC, and headquartered in the United Kingdom, this journal has become a cornerstone in the field since its inception in 2000, with a remarkable focus on health policy, nursing ethics, and the complex legal aspects intertwining with healthcare practices. With an impressive Q1 ranking across multiple categories, including Health Policy and Health (Social Science), it ranks among the top journals globally—particularly notable with its Scopus rankings reflecting a strong 85th percentile in Nursing and an 81st percentile in Social Sciences. As an open-access publication, BMC Medical Ethics ensures that research findings are readily accessible, fostering a collaborative environment for researchers, practitioners, and students alike. The journal's commitment to ethical discourse not only advances academic inquiry but also shapes the practices and policies that govern healthcare delivery; thus, making it an invaluable resource for those engaged in the advancement of medical ethics.

THEORETICAL MEDICINE AND BIOETHICS, published by SPRINGER, is an esteemed journal dedicated to exploring the complex intersections of medicine, ethics, and law. With its ISSN 1386-7415 and E-ISSN 1573-1200, this journal serves as a vital platform for scholars, practitioners, and students interested in the ethical implications of medical practices and innovations. Although it currently holds a Q4 impact factor in the categories of Issues, Ethics and Legal Aspects and Medicine (Miscellaneous) as of 2023, its relevance is amplified by its commitment to fostering critical discourse in a rapidly evolving field. The journal features a diverse range of articles that address profound ethical dilemmas in healthcare, making it a significant resource for contemporary research from 1997 to the present. As an open-access journal, it ensures that cutting-edge knowledge is readily available, inviting contributions that challenge conventional thought and advance the field of bioethics.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.